ONCT - Oncternal Therapeutics Inc. (ONCT) CEO James Breitmeyer on Q2 2019 Results - Earnings Call Transcript
Oncternal Therapeutics, Inc. (ONCT)
Q2 2019 Results Earnings Conference Call
August 08, 2019, 05:00 PM ET
Company Participants
Richard Vincent - Chief Financial Officer
James Breitmeyer - President and CEO
Conference Call Participants
Hartaj Singh - Oppenheimer
Kumar Raja - Brookline Capital Market
Presentation
Operator
Greetings. And welcome to Oncternal Therapeutics Q2 Earnings Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder this conference is being recorded.
I would now like to turn the conference over to your host